# Mayinglong Pharmaceutical Group Co Ltd – FDA Inspection, Mar 14, 2025

Source: https://www.keypedia.com/records/fda_inspections/mayinglong-pharmaceutical-group-co-ltd/1ad73c7c-df72-408e-a5c5-66c29048c1d6
Source feed: FDA_Inspections

> FDA inspection 1264613 of Mayinglong Pharmaceutical Group Co Ltd, March 14, 2025. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1264613
- Company Name: Mayinglong Pharmaceutical Group Co Ltd
- Inspection Date: 2025-03-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 1

## Related Documents

- [FDA Inspection 1051249 - 2018-04-13](https://www.keypedia.com/records/fda_inspections/mayinglong-pharmaceutical-group-co-ltd/afbc3f22-1afe-4d7c-b2ac-dfa83829e9db)
- FDA Inspection 955742 - 2015-12-11

## Related Officers

- [Investigator](https://www.keypedia.com/people/vivin-george/0b0ee298-a577-4bee-b18e-42da0c3bb148)

Company: https://www.keypedia.com/companies/mayinglong-pharmaceutical-group-co-ltd/74ea2093-120b-44f4-9f36-13b2ec118a13

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8